Vertex Pharmaceuticals (VRTX) - FREE Research Report

Connolly Thomas who is SVP, Human Resources at Vertex Pharmaceuticals sold 150 shares at $61.05 on Nov. 19, 2013. Following this transaction, the SVP, Human Resources owned 4,252 shares meaning that the stake was reduced by 3.41% with the 150 share transaction.

Pace Megan E who is SVP, Corp. Communications at Vertex Pharmaceuticals sold 93 shares at $60.97 on Nov. 19, 2013. Following this transaction, the SVP, Corp. Communications owned 17,271 shares meaning that the stake was reduced by 0.54% with the 93 share transaction.

The shares most recently traded at $64.61, up $3.64, or 5.63% since the insider transaction. Historical insider transactions for Vertex Pharmaceuticals go as follows:

  • 4-Week # shares sold: 9,050
  • 12-Week # shares sold: 38,067
  • 24-Week # shares sold: 60,208

The average volume for Vertex Pharmaceuticals has been 2.6 million shares per day over the past 30 days. Vertex Pharmaceuticals has a market cap of $14.4 billion and is part of the health care sector and drugs industry. Shares are up 47.23% year to date as of the close of trading on Tuesday.

Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. Currently there are 12 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on VRTX - FREE

TheStreet Quant Ratings rates Vertex Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Vertex Pharmaceuticals Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Auto Industry's Running Out of Gas and Analyst Suggests Government Support May Be Down the Road

Analysts' Actions -- Arista Networks, CF Industries, Duke Energy, FireEye and More

Auto Retailers With U.K. Interests Get Clobbered Following 'Brexit' Vote

CarMax Results Show Expectations Still Too High for Auto Dealers

CarMax Results Show Expectations Still Too High for Auto Dealers

Auto Industry Has Many Levers to Pull if Federal Reserve Lifts Interest Rates